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The SEC14 family of proteins spans across many kingdoms. These proteins all contain the 
SEC14 lipid binding domain and bind a wide variety of different lipids. SEC14 proteins play 
crucial roles in cellular health including signal regulation and membrane trafficking, and often 
when mutated, lead to diseases such as cancer and neural degeneration. Lipid binding is closely 
tied to SEC14 protein function but cannot easily be predicted without taxing lipid binding 
experiments. Residues responsible for the lipid binding profile of Patellin1 (PATL1) a SEC14 
protein from Arabidopsis were identified through homology modeling and used to explain 
PATL1’s binding profile. These models could also be used to predict the lipid binding profile of 
Saccharomyces cerevisiae SEC14 (ScSEC14). Fat blots were conducted to measure the lipid 
binding of purified PATL1 and ScSEC14. PATL1 fat blots suggested binding to 
phosphatidylcholine (PC), phosphatidylinositol (PI) and phosphatidylinositol-5-phosphate 
(PI(5)P) with increasing affinity and very little binding to phosphatidylinositol-4-phosphate 
(PI(4)P) consistent with the homology model and previous binding studies performed using 
vesicle co-sedimentation. ScSEC14 fat blots showed binding to PI(5)P as predicted by the 
homology models. Mutagenesis of identified residues in PATL1 was performed as preliminary 
work for applying the model toward making changes in binding profiles. Successfully 
developing a lipid binding model will provide an alternative to lipid binding experiments and 
provide a better understanding of the mechanism of action of lipid binding proteins and of the 






Functions of SEC14 proteins 
The SEC14 family of proteins is defined by homology to the globular Saccharomyces 
cerevisiae secretory protein ScSEC14.  It is a diverse family with members spanning across 
eukaryotic kingdoms, from yeast to mammals (1). The proteins share high sequence homology 
and the ability to bind lipids in a hydrophobic cleft (Figure 1). Despite having high sequence 
homology, these proteins bind lipids with profiles that are specific to individual proteins and that 
differ from protein to protein (2). This variability is largely because residues contained in the 
binding cleft of these proteins are highly variable especially around the region were the lipid 
head groups bind (3).  
  
Figure 1: ScSEC14 is a globular protein with a hydrophobic cleft in which lipids bind. The figure 
created in PyMOL (4) (PDB 1aua) shows the protein co-crystallized with 2 molecules of octyl β-
D-glucopyranoside in cyan. Carbon atoms are shown in green, nitrogens in red, sulfur in yellow, 
and oxygens for both protein and ligand in red. 
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SEC14 proteins play a wide range of roles that are crucial to cellular health (Table 1). 
These include the regulation of the signaling proteins, Ras and Rho GTPases, through GTPase 
activating proteins (GAPs) that encourage hydrolysis of GTP, and guanine nucleotide exchange 
factors (GEFs) which facilitate the exchange of GDP for GTP. One example of a SEC14 GAP is 
the tumor suppressor neurofibromin 1 (NF-1) (5). SEC14 GEFs include DBS (5) and DBL (6).  
Another role played by SEC14 proteins is regulation of membrane trafficking within the 
cell as performed by ScSEC14 (1, 7). The control of tyrosine phosphorylation, which is involved 
in differentiation, oncogenesis, and the development of the innate immune system through 
receptor tyrosine kinase (RTK) based signaling, is yet another function conducted by SEC14 
proteins an example of which is the cytosolic megakaryocyte protein tyrosine phosphatase PTP-
MEG2 (8). 
Table 1: Examples of SEC14 proteins and their functions 
Protein Class/Type Function 
Yeast ScSEC14 Phosphatidylinositol transfer 
protein (PITP) 
Membrane trafficking (1, 7) 
Human Neurofibromin 1 
(NF-1) 
GTPase activating protein (GAP) Cellular signal regulation (5) 
Mouse DBS Guanine nucleotide exchange 
factor  (GEF) 
Cellular signal regulation (5) 
Human DBL Guanine nucleotide exchange 
factor  (GEF) 
Cellular signal regulation (6) 




The importance of SEC14 proteins is evident in the serious diseases that occur when 
these proteins are not functional. For example, cancer develops when the signaling regulators 
DBS and DBL are mutated in their SEC14 domain (9-12). Neural degeneration including ataxis 
also occurs as a result of mutations in human tocopherol associated protein (hTAP), a SEC14 
protein (13). Another disease that is also a result of a nonfunctional SEC14 protein is 
Neurofibromatosis type 1 which occurs when the tumor suppressor NF-1 is mutated (5, 14). 
Lipid binding of SEC14 proteins 
Lipid binding is important for the function of almost all SEC14 proteins. The main lipid 
interacting partners of SEC14 proteins are phospholipids, which are the major component of the 
plasma membrane. These phospholipids maintain cellular structure and also regulate signaling 
receptors by controlling the spatial localization of the proteins involved, allowing them to 
interact. For example, some phospholipids localize GEFs to the plasma membrane and enable 
them to access the GTPases they act on (5, 11, 12, 15). Phospholipids also directly activate the 
function of some SEC14 proteins such as PTP-MEG whose ability to drive the fusion of 
secretory vesicles is enhanced by the binding of phosphoinositides (16). 
Of the membrane forming phospholipids, the phosphoinositides are only a minor 
component making up less than 1% of the total lipids present, yet they play the majority of lipid-
based signaling roles in the cell (17). They are optimal for signaling roles because small changes 
in their amounts constitute large fold changes.  Their regions of influence extend beyond 
regulation at the plasma membrane to regulation of some nuclear proteins (18, 19). 
Each SEC14 protein has a unique lipid binding profile (Table 2). Some examples of 
proteins and the lipids they are known to bind include SsSEC14 which binds 
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phosphatidylinositol (PI) and phosphatidylcholine (PC) (20) to extents that are comparable to 
each other. Patellin1 (PATL1), an Arabidopsis thaliana protein found in the cell plates of 
dividing cells, binds, in order of decreasing affinity, phosphorylated derivatives of PI or 
phosphoinositides, phosphatidylinositol-5-phosphate (PI(5)P), phosphatidylinositol-4,5-
diphosphate (PI (4,5)P2), phosphatidylinositol-3-phosphate (PI(3)P), PI, and PC (21). Other 
examples are hTAP which binds PI, PC and phosphatidylglycerol (PG) (13), and the tyrosine 
phosphatase PTP-MEG2 which binds PI(4,5)P2 (16), phosphatidylinositol-3,5-diphosphate 
(PI(3,5)P2) (3), phosphatidylinositol-3,4,5-triphosphate (PI(3,4,5)P3) (3, 22), and 
phosphatidylserine (PS) (23). NF-1 binds PG, phosphatidylethanolamine (PE), PC, PS, and PI 
with decreasing strength in that order (24) while p45 binds PI(3,4,5)P3 (25, 26). 
Table 2: Examples of SEC14 proteins and some of their lipid substrates 
Protein Lipids bound 
SsSEC14 PC, PI (20) 
Patellin1 PI(5)P > PI (4,5)P2 > PI(3)P >PI > PC (21) 
hTAP PI, PC, PG (13) 
PTP-MEG PS, PI(3,4,5)P3, PI(3,5)P2, PI (4,5)P2 (3, 16, 22, 23) 
NF-1 PI(4)P > PI(5)P > PI(3)P > PG > PE>PC>PS>PI (24, 27) 
p45 PI(3,4,5)P3 (25, 26) 
 
Some of the differences in lipids bound can be explained by the overall charge conferred 
upon the binding cleft by the amino acids present. For example, PTP-MEG2 is generally more 
positively charged in its binding pocket than ScSEC14 and preferentially binds the more 
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negatively charged phosphoinositides more strongly than does ScSEC14 (2, 3). In the same way, 
PATL1 has positively charged residues in its lipid binding pocket and has been found to bind 
negatively charged PI and PI(5)P with a higher affinity than it does neutral PC (21). Overall 
charge however, does not seem to completely explain the variation in binding profiles as binding 
preference cannot be deduced simply from the charge. 
Measuring Lipid Binding 
The vital role played by phosphoinositides makes it important to understand the 
interactions between SEC14 proteins and lipids, as they would give insight into the localization 
and functions of the proteins. Knowledge of ligands bound has been used as a way of developing 
possible experimental approaches to probe function of proteins (27). As such, different methods 
of measuring these interactions are constantly employed, expanding the knowledge base of the 
lipid binding profiles of multiple SEC14 proteins. One such method is the vesicle co-
sedimentation assay which identifies the lipids bound by a SEC14 protein based on co-
sedimentation with lipid vesicles after ultra-centrifugation (21, 25, 28). A drawback of this 
method is its low level of reproducibility. 
 Figure 2: Schematic of the protein lipid overlay assay.  
Another method that can be used to observe qualitatively the lipid binding of a protein is 
fluorescence spectroscopy. All proteins containing tryptophans are fluorescent with the 
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wavelength maxima dependent on the environment in which the fluorescent residues are. 
Fluorescence can be used to measure binding if a lipid binding protein has tryptophans in its lipid 
binding domain.  Because emission spectra of residues experience a red shift when moved to less 
polar environments (29), the emission spectrum of a protein after binding to hydrophobic lipid 
should also exhibit a red shift compared to that of unbound protein. Our attempts at using this 
method to measure lipid binding in PATL1 failed as results were inconsistent (30).  
 
Figure 3: a) Structure of SsSEC14 showing the position of the two conserved residues GLU-207 
and LYS-239 highlighted with a yellow box. b) These residues form a salt bridge. 
Therefore, the method that was used to measure lipid binding in PATL1 is the protein 
lipid overlay assay or fat blot. This method uses small amounts of lipid immobilized on 
nitrocellulose. Binding by protein is probed by exposure of the nitrocellulose to the epitope 
tagged protein and detection is performed by immunological detection (Figure 2) (3, 26, 31, 32). 
This method is advantageous because it uses very small amounts of costly lipid and allows one to 




Modeling Lipid Binding 
In addition to understanding protein-lipid interactions of SEC14 proteins through lipid 
binding experiments, in silico structural studies to understand the molecular mechanisms of 
binding have been conducted. The first of these have involved identification of residues 
important for the overall fold of SEC14 proteins which enable them to be functional and to bind 
lipids. These studies have revealed that the two residues, Glu207 and Lys239, which are 
conserved in all SEC14 proteins and have been shown to be crucial for the lipid binding function 
through mutagenesis studies (5, 33), form a salt bridge holding the protein together (Figure 3).  
a.  
b.   
Figure 4: The structure of PATL1. a. A representation of PATL1 showing locations of the N-
terminal, SEC14, and GOLD domains. b. A homology modeling derived 3D structure of the 
SEC14 domain of PATL1 bound to a PI molecule with ScSEC14 as the template sequence (34). 
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The difficulty often encountered in lipid binding experiments and the infeasible task of 
taking these measurements on every single SEC14 protein without a characterized binding 
profile make the development of a method that predicts the lipids bound from the protein’s 
sequence very attractive. Nevertheless, researchers have not extensively done this for SEC14 
proteins yet. Presently, 2D sequences decoded from 3D structures have been used to create 
signatures or “barcodes” for proteins that bind PI and PC (35), but these barcodes have not yet 
been shown to correctly predict the binding of either PI or PC (36). This study attempts to use 
structural information to understand the mechanism behind the binding of phosphoinositides by 
the SEC14 protein PATL1. The structural information when translated to the sequence of the 
protein can be used as a template for predicting potential binding events in other SEC14 proteins 
by comparing their sequences to PATL1’s.  
  
Figure 5: Residues in PATL1’s SEC14 domain (green) identified by the computational 
homology model to interact directly with the bound PI molecule (cyan) (34). Oxygen atoms are 




The crystal structure of ScSEC14 (33) was used to develop a computational homology 
model of the SEC14 domain of PATL1 bound to PI (34). The model was created in PATL1 
because it was one of the few SEC14 proteins whose lipid binding had been characterized and it 
showed strong binding to PI(5)P which had not been observed in many other proteins previously 
(21). The use of computational homology models is an approach that has been used in the past by 
other researchers to model the structure of PTP-MEG2 (3). The PATL1 model identified five 
residues Arg11, Arg90, Thr172, Arg175 and Lys179 as potentially influencing the lipid binding 
by PATL1 because they were in close proximity to the bound PI molecule and were oriented to 
allow interactions with the lipid (Figure 5). 
Table 3: Targets of identified residues in PATL1 binding model 







Arg90 and Lys179 are predicted to encourage binding of phospholipids with no 
selectivity because they are oriented toward the glycerol backbone and the phosphate that are 
features of all glycerol phospholipids. The other residues give preference to specific 
phosphoinositides. Positively charged Arg11 and Arg175 are pointed toward the 5- and 3-
positions of the inositol head group respectively and lead to the prediction that binding of a 
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phosphoinositide phosphorylated at the 5-, or 3- position, i.e. PI(5)P or PI(3)P, would be 
favorable. Neutral Thr172 is oriented toward the 4- position of the inositol head group and while 
in its uncharged state it is not predicted to confer any binding advantage to a phosphoinositide 
phosphorylated at this position, it is predicted to potentially favor binding if it were mutated to a 
positively charged residue. Previous work by the Peterman group identified lipids bound by 
PATL1 as PI(5)P, PI (4,5)P2, PI(3)P,PI, and PC with decreasing affinity in that order(21). PI(4)P 
was bound very weakly in relation to the other phosphoinositides. 
Here, we verify the homology model by measuring wild type PATL1’s lipid binding 
using fat blots. Further, we used the model to predict the lipid binding of ScSEC14. Having a 
functional predictive model will give an understanding of what factors contribute to the 
differential lipid binding by SEC14 homologues and allow predictions of the functions for 
uncharacterized members of the family. This model will enable the design of proteins that could 
target specific lipids of interest, particularly PI(5)P and, which does not of yet have characterized 
proteins that targets it (17). The targeting proteins when attached to fluorescent tags can be used 










Materials and methods 
Protein expression  
To express our proteins of interest, PATL1 and ScSEC14, we used the pGEX6P-1 vector 
(gift from Peterman lab, Wellesley MA). The PATL1 gene had been inserted into BamH1 and 
Sal1 sites while the ScSEC14 gene had been inserted into EcoR1 and Xho1 sites of the 
polylinker. The vector was expressed in BL21 E. coli.  
Bacteria were grown until OD600 was 0.9 – 1, then protein overexpression was induced 
using 0.5 M isopropyl-β-D-1-thiogalactopyranoside (IPTG) at 37 °C for 4 hours. Centrifugation 
at 7000xg was performed to remove the media before bacteria were washed in about 200 mL 1X 
PBS. Cells were lysed in lysis buffer [1% triton, 0.2 M NaCl, 2 mM EDTA, 20 mM sodium 
phosphate (NaPi) pH 7.5, 5 mM dithiotheritol (DTT), 2 Roche cOmplete mini protease inhibitor 
tablets/50 mL buffer (Roche diagnostics, Indianapolis IN)] and sonicated at 70% duty cycle with 
a microson™ ultrasonic probe sonicator (Qsonica, Newtown CT) to complete the lysis. 
Glutathione-sepharose beads (GE Healthcare, Pittsburgh PA) were used to affinity purify the 
protein from the lysate in an hour long incubation at 4 °C. The beads were then washed about 8 
times in cold 1X PBS and protein was eluted from them using a pH 8 buffer containing 0.15 M 
NaCl, 100 mM Tris, and 20 mM glutathione. The concentration of protein was measured using a 
NanoDrop spectrophotometer (Thermal Scientific, Wilmington DE). Protein identity and purity 
were ascertained by MALDI-TOF using a Bruker auto flex mass spectrometer (Bruker Daltonics, 
Billerica MA) and SDS-PAGE with Coomassie staining. 
MALDI-TOF 
Spectra were taken of protein in 0.1% trifluoroacetic acid (TFA) using matrix made of 20 
mg/mL sinapinic acid in 50% acetonitrile (ACN), 0.1% TFA. Samples were ziptipped to remove 
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salts before samples were spotted onto a polished steel target. Zip tipping involved equilibration 
of the ziptip (EMD Millipore, Temecula CA) using 100% ACN and 0.1% TFA followed by 
binding of the protein to the ziptip and washing with 0.1% TFA. A solution of 70% ACN and 
0.1% TFA was used to elute the bound protein. Protein sample was added to the target and 
allowed to dry followed by overlaying and drying of an equal amount of matrix before 
measurements were taken. Linear mode settings were used. 
Mutagenesis 
To generate the mutations, plasmid was extracted from BL21 cells containing WT 
PATL1 using a QIAprep MiniPrep kit (Qiagen). Site-directed mutagenesis was performed on the 
plasmid using the following primers with altered bases bolded. Numbering is based on the 




Forward: CCTTAAAGTCGCTTGCACGGAGGAATTTCG  




















Two mutagenesis reactions were run containing either 20 ng or 40 ng of plasmid. Each 
reaction also contained 125 ng each of primer forward and reverse, 1X Phusion® HF buffer (5 
µL of 5X), 1 µL 10 mM dNTP mix, and 1µL Phusion® High-Fidelity DNA polymerase (New 
England Biolabs, Ipswich MA) in a 50 µL aqueous reaction. Polymerase chain reaction (PCR) 
was performed using the following parameters: 95 °C for 30 seconds then 16 cycles at 95 °C for 
30 seconds, 55 °C for 1 minute and 68 °C for 14 minutes. When the reaction was completed, the 
DNA was digested with Dpn1 for 40 minutes at 37 °C and immediately electroporated into 
electrocompetent DH5α bacteria.  
Transfection 
Bacteria were transformed through electroporation. Electrocompetent DH5α and BL21 E. 
coli bacteria were mixed with 20 ng of plasmid DNA on ice and transferred to an electroporation 
cuvette. A current of 1800V was run through them in an Eppendorf Electroporator 2510 
(Eppendorf, Hauppauge NY) and they were immediately resuspended in 37 °C SOC media. 
Recovery was conducted at 37 °C for 1 hour in a shaker incubator before the cells were plated on 
LB-Agar plates with 50 µg/mL ampicillin and allowed to grow at 37 °C overnight.  
Enzymatic digest 
The R11S mutation introduced an additional Cac8I restriction site in the mutant. To 
screen for successful transformations, a reaction of 5 units of Cac8I (New England Biolabs, 
Ipswich MA) on 100 ng WT and mutant plasmids was conducted at 37 °C for 5 – 15 minutes. 
The enzyme was inactivated at 65 °C for 20 minutes and the DNA was run on a 1% agarose gel 
with SYBR® safe for visualization. Predictions for the banding pattern were obtained using the 




To measure lipid binding of PATL1 and ScSEC14, we used the fat blot method adapted 
from Munnik et al. (39). Lipid was prepared in two different methods. In the first, lipid vesicles 
composed of our lipid of interest mixed with PC in a 1:10 ratio in HEPES buffer were prepared 
as described below. In the second, each lipid of interest was suspended in a 2:1:0.8 solution of 
methanol: chloroform: water. Prepared lipids or vesicles were spotted onto nitrocellulose 
membranes and allowed to dry for 1 hour. Once dry, the membranes were blocked in a pH 7.5 
blocking buffer [3% fatty acid free bovine serum albumin (BSA) in 150 mM NaCl, 50 mM Tris-
HCl] for another hour. Blocked membrane was then incubated in 0.5 µg/mL protein in blocking 
buffer with 0.1% tween at 4 °C overnight. Detection of bound protein was performed using 
1:2000 rabbit-anti-GST primary antibodies (Invitrogen, Eugene OR) in blocking buffer with 
0.06% tween after the blot had been washed 3 times for 5 minutes in wash buffer [150mM NaCl, 
50mM Tris-HCl pH 7.5, and 0.1% tween]. This was followed by the incubation of the blot in 
1:5000 AlexaFlour 488 goat-anti-rabbit secondary antibodies (Invitrogen, Eugene OR) after 3 
more 5 minute washes. The blot was washed after the antibody incubations then fluorescence 
was detected using Imagelab™ software on a molecular imager gel doc (Bio-Rad, Hercules CA). 
Preparation of vesicles 
 Lipid vesicles were made from pure egg PC or mixed with soy PI, 18:1 PI(4)P or 18:1 
PI(5)P in a 10:1 ratio. All lipids were obtained from Avanti Polar Lipids and dissolved in 
chloroform when purchased or right before use. To make the vesicles, the chloroform was 
evaporated using a nitrogen stream and the lipid cake was desiccated under a vacuum overnight 
to remove all moisture. The lipid was then resuspended in 10 mM HEPES buffer and subjected 
to 5 freeze thaws in liquid nitrogen and a 37 °C waterbath. Sizing of the vesicles was performed 
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by extrusion through nuclepore track etched membranes (Whatman, United Kingdom) with 0.1 
µm pores at 50° C in a lipid extruder (Avanti Polar lipids, Alabaster AL). Prepared vesicles were 
stored at 4° C. 
We used the phosphorous assay to quantitate the amount of lipid in the vesicles. 
Standards of 0, 0.0325 µmoles, 0.065 µmoles, 0.114 µmoles, 0.163 µmoles, and 0.228 µmoles of 
phosphate were used and measurement of vesicles was done in duplicate. In the assay, standards 
and vesicle samples were mixed with 8.9 N H2SO4 and heated at 175 – 210 °C for 25 minutes. 
This was followed by the addition of 30% H2O2 and heating at 175 – 210 °C for 30 minutes. 
Finally, 10% ascorbic acid and 2.5% ammonium molybdate were added and the samples were 
boiled for about 5 minutes. Absorbance at 820 nm was taken and a standard curve generated 
from the absorbance of the standards was used to calculate concentration of the vesicles. 
Circular Dichroism 
3.95E-8 M PATL1 or 1.25E-7 M ScSEC14 protein samples were prepared in 1mM 
sodium phosphate buffer with 4.5 mM KF and 0.1 mM EDTA, for circular dichroism. Spectra 
were collected in an Olis DSM 1000 CD spectrophotometer (Olis, Bogart GA) at 25 °C with an 
integration time of 70 seconds from 195 – 250 nm. Three scans were collected and averaged. 
Three blank scans for the buffer without the protein were collected and their average was 
subtracted from the protein average to obtain the background adjusted ellipticity θ. Molar 
circular dichroism was calculated using the formula  
Δε =  θ/[(3298)(number of residues)(molarity of protein)]  







BL21 E. coli bacteria expressing GST-PATL1 were grown until OD600 was between 0.9 
and 1 at which point they were induced with 0.5 M IPTG and grown for an additional 4 hours at 
37 °C. Protein was obtained and purified from lysed bacteria using affinity purification with 
GST-sepharose beads. Purifications starting with 500 mL of bacterial culture typically yielded 
about 3 mg of protein. We used SDS-PAGE to verify the identity of the purified protein. GST-
PATL1 weighs about 89 kDa and a band was observed at this mass on gels with purified protein. 
The gel also showed that induction increased the amount of protein expressed, purification got 
rid of most of the other proteins in the cell lysate, and elution was effective as subsequent 
elutions contained less protein (Figure 6). 
 
Figure 6: Arabidopsis PATL1 was expressed using the pGEX6P-1 vector in BL21 E. coli and 
purified. Samples obtained at various points of expression and purification were run on an 7.5% 




PATL1’s secondary structure as predicted through homology modeling is composed of 
comparable amounts of alpha helices, beta sheets and random coils(34) (Figure 7). We took 
circular dichroism spectra of our purified protein in phosphate buffer. The spectra we obtained 
did not show dominance of  negative peaks at 208 nm and 222 nm characteristic of alpha helices, 
a negative peak at 218 nm characteristic of beta sheets, or a positive peak at 212 characteristic of 
random coils, suggesting mixed secondary structure as expected (Figure 7). 
 
 
Figure 7: Secondary structure of PATL1. Top, cartoon representation of PATL1’s SEC14 
domain developed through homology modeling(34). Bottom circular dichroism spectrum of 0.12 
µM whole GST-tagged PATL1 in 1 mM phosphate buffer pH 7.5. 
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PATL1 Lipid Binding 
To measure PATL1’s lipid binding we used a protein lipid overlay assay, or fat blot. 1 ng 
of lipid suspended in a 2:1:0.8 mixture of methanol: chloroform: water was spotted onto a 
nitrocellulose membrane and allowed to dry. The membrane was blocked in fatty acid free BSA, 
incubated in 0.5 µg protein overnight at 4 °C, and incubated in 1:2000 rabbit-anti-GST 
antibodies followed by 1:5000 Alexa fluor® 488 goat-anti-rabbit secondary antibodies. The blot 
was washed after each incubation. Finally, fluorescence was detected on the membrane as proxy 
for the bound lipid. Most of the time, fat blots showed PATL1 binding to PI(5)P, PI, and PC in 
order of decreasing affinity (Figure 8). This agreed with previously obtained results by the 
Peterman group (21). 
  
Figure 8: Lipid binding of PATL1. Fat blot of 0.5 µg/mL PATL1 binding to 1 ng lipid samples 
immobilized on a nitrocellulose membrane. Bound protein was detected using anti-GST primary 
and Alexa 488 secondary antibodies. 
 
Some fat blots, however, showed variation in the binding profile, showing binding to PC 
to be greater than binding to PI only or both PI and PI(5)P (Figure 9). This discrepancy signaled 
a possible variation in the concentration of lipid used. Lipid mixtures used for the fat blot were 
made to a concentration of 1µg/µL by diluting PC and PI from stocks of 25 mg/mL and 10 
mg/mL respectively. The phosphoinositides were purchased as a 100 ng dry powder and were 
brought to 1µg/µL by adding 100 µL of the methanol/chloroform/water mixture. This 
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concentration of lipid proved to be insufficient for detection and quantitation by the phosphate 
quantitation assay and made it difficult to verify the amounts of lipid used on each spot and to 
validate the varying trends observed in the fat blots. To overcome this challenge we made PC 
vesicles in 10 mM HEPES buffer doped with our lipids of interest in a 10:1 ratio. The vesicles 
had a large enough concentration to be quantitated through the phosphate assay. 
  
Figure 9: Variation in fat blots. Blots of 0.5 µg/mL PATL1 binding to 1 ng lipid samples.  
With vesicles of known concentration, we spotted nitrocellulose membranes with vesicles 
to a total of either 1 ng or 1.5 ng phosphate on each spot and performed fat blots. These fat blots 
showed greatest binding to PI(5)P and the least binding to PI(4)P for both amounts. At the lower 
amount, binding to PI was greater than binding to PC while at the higher amount binding to PC 
seemed stronger (Figure 10). This could mean binding to PC is greater than PI at higher 
concentrations but saturation in the PC spot makes it difficult to make this a definite statement 
(Figure 10). The low level of binding of PATL1 to PI(4)P was reported in previous studies (21) 
and is consistent with our homology model. 
 
Figure 10: Lipid binding of PATL1 using PC vesicles doped with different lipids. 0.5 µg/mL 
PATL was used and total amount of vesicles/ spot was a) 1 ng and b) 1.5 ng 
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Lipid binding of ScSEC14  
With methods of expression and measuring the lipid binding of PATL1 established, we 
were able to begin testing our homology model. The homology model predicted that the residues 
responsible for PATL1’s lipid binding were Arg11, Arg90, Thr172, Arg175 and Lys179. 
Although Arg90 and Lys179 did not provide any specificity in lipids bound, Arg11, Thr172 and 
Arg175 are positioned to influence the binding of PI(5)P, PI(4)P, and PI(3)P respectively. In 
PATL1, the binding of PI(4)P is not expected because Thr172 is not positively charged. If 
correct, the model could be used to predict the binding profiles of other SEC14 proteins by 
comparing the sequences of their SEC14 domains to that of PATL1 and regarding the 
conservation the identified residues. An identical or similar residue in the same position can be 
predicated to enable binding of a targeted lipid. 
We therefore, compared the sequences of the SEC14 domain of PATL1 and the yeast 
protein ScSEC14 in an attempt to predict what lipids ScSEC14 would bind. The alignment 
showed that two out of the five residues, Arg11 and Lys179, were conserved in ScSEC14 
(Figure 11). The conservation of Arg11 suggested binding of ScSEC14 to PI(5)P which had not 
been tested previously. 
To test the prediction of the homology model, we measured the lipid binding of 
ScSEC14. The protein was expressed in the pGEX6P-1 vector in BL21 E. coli cells. As with 
PATL1, bacteria were grown until OD600 was between 0.9 and 1 at which point they were 
induced with 0.5 M IPTG and grown for 4 hours at 37 °C to overexpress the protein. The 
bacteria were lysed and purification of the protein was achieved using GST-sepharose beads. 




Figure 11: Sequence alignment of PATL1’s SEC14 domain and ScSEC14. The five residues 
necessary in lipid binding are highlighted with arrows, blue for the conserved between these two 
proteins and red for the ones that are different. 
As with PATL1, we ran SDS-PAGE to verify that we had purified the right protein. 
Additionally, we collected the mass spectrum of the protein using MALDI-TOF. Both gel 
images and mass spectra showed a 63 kDa protein, the predicted mass of GST-tagged ScSEC14 
(Figure 12). 
To further characterize our purified ScSEC14, we measured its secondary structure using 
circular dichroism. Like PATL1, ScSEC14 is mixture of alpha helical, beta sheet, and random 
coil secondary structures. Again the circular dichroism spectrum obtained did not have dominant 
peaks that are characteristic of alpha helices, beta sheets, or random coils pointing to a mixed 
secondary structure composition (Figure 13). 
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a       b  
Figure 12: GST-tagged ScSEC14 was expressed in BL21 E. coli bacteria and affinity purified 
using GST sepharose beads. a) SDS-PAGE of the  two elutions from the purification. b) 
MALDI-TOF mass spectrum of the purified protein. 
 
We used the fat blot assay with lipids in methanol:chloroform:water to measure 
ScSEC14’s lipid binding and verify the prediction that it bound to PI(5)P. Previous 
measurements of lipid binding in this protein had only focused on its abilty to bind PC and PI, 
the two lipids whose exchange between membranes it is involved with in the yeast secretory 
pathway (35). Our fat blots showed that ScSEC14 bound PI and PC as reported by previous 
studies (20) but most importantly that it also bound PI(5)P as predicted by our homology model 
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(Figure 14). In most fat blots, we found that binding to PI and PC was to similar extents for both 
lipids while binding to PI(5)P was stronger than binding to the other two lipids (Figure 14 a). A 
few times however, binding to PC appeared slightly stronger than binding to PI but binding to 
PI(5)P remained strongest (Figure 14 b). The binding to PI(5)P supports the predictive nature of 
our model for binding in SEC14 proteins other than PATL1.  
Figure 13: Secondary structure of ScSEC14. A circular dichroism spectrum was taken of 0.12 
µM ScSEC14 in 1 mM phosphate buffer pH 7.5. 
Mutagenesis 
Another potential use of the model is the modification of the binding profile of different 
SEC14 proteins. Knowing which residues are involved in lipid binding can allow us to remove 
the ability to bind some lipids and to induce the ability to bind others. In PATL1, we began 
efforts to modify lipid binding by creating via Quickchange mutagenesis using Phusion® 
polymerase five different proteins, each with a mutation of one of the five residues. Primers used 
are listed in the methods section. The following mutations were made to eliminate the positive 
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charge and binding ability for the four positively charged residues and introducing a positive 
charge for Thr172 to induce binding of PI(4)P: 
 Arg 11  Ser   
Arg 90   Ser   
Thr 172  Arg   
Arg 175   Ser    
Lys 179  Thr 
Charged residues were mutated to neutral polar residues rather than nonpolar ones to 
enable attribution of binding specifically to charge-charge. Using polar residues could also be 
used to evaluate the validity of the claim that PI(4)P is not bound by PATL1 because the Thr 
residue located near the 4- carbon of the PI head group is only polar and not charged. These 
changes were also favorable because each required only a single base pair change in the DNA 
sequence. 
Mutated plasmid from the PCR reactions was transfected into DH5α E.coli after digestion 
with DpnI. The bacteria were grown on LB-Agar plates with 50 µg/mL ampicillin. 
a     b  
Figure 14: Lipid binding of ScSEC14. 0.5 µg/mL ScSEC14 was assayed for binding to 1 ng lipid 
samples. a. and b. are two representative fat blots obtained.  
 
From the DH5α bacteria transfected with DNA with the R11S mutation, plasmid DNA 
was extracted using a Qiagen miniprep kit. The DNA was sequenced and enzymatically digested 
to verify the introduction of the correct mutation. Cac8I was used for the enzymatic digest 
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because an extra restriction site for the enzyme was created in this mutant. Digestion products of 
the wild type and mutant protein were predicted to show different band patterns by Geneious 
software (Biomatters, NZ). The result obtained did indeed show different band patterns on a 1% 
agarose gel but not at the predicted masses. The WT digested bands ran at much higher masses 
than predicted while the mutant bands ran at the predicted 0.5 – 1.5 kb predicted even though 
their cutting pattern was similar to that predicted for the wild type (Figure 15). This could mean 
the created mutant was a mixture of the mutant and wild type population. 
  
Figure 15: Site directed mutagenesis of WT PATL1. WT and mutated plasmid DNA were 
digested with Cac8I and run on a 1% agarose gel with SYBR® Safe staining. a. Cut pattern 







In this study, we successfully expressed and purified both PATL1 and ScSEC14 proteins 
in BL21 E. coli using the pGEX6P-1 vector. Protein was shown to be pure through SDS-PAGE 
and MALDI-TOF which showed a single band and peak respectively. Circular dichroism spectra 
of each protein were taken showing the secondary structures consistent with ScSEC14’s crystal 
structure (33) and PATL1’s homology model (34). 
The fat blot method provided a means of measuring lipid binding. Our results suggested 
that PATL1 bound to PI(4)P, PC, PI, and PI(5)P with increasing affinity. While the trend of 
binding to PC and PI was at times variable, PI(5)P was always bound with the greatest affinity 
and PI(4)P with the least. These results concur with the model which predicts binding to PI(5)P 
but poor binding to PI(4)P due to the positions of positively charged residues in PATL1’s 
binding cleft. 
This method was successful in providing qualitative results but also had some limitations. 
Firstly, the fat blot did not provide quantitative values (40, 41) of the binding of the proteins to 
different lipids because at first, the amount of lipid could not be exactly quantified. However, 
even when the lipids were quantified, quantitative values of fluorescence intensity were difficult 
to obtain because the intensity of the fluorescence due to the highest affinity binding was often 
so much higher than the intensity due the lowest affinity binding that the former appeared 
saturated. Nevertheless, because vesicles could be quantified using the phosphate assay and 
ensured uniform lipid amounts on the blot, variation in intensities could be attributed solely to 
the difference in affinity of different lipids and not their concentrations. 
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A second limitation of the fat blot is its difference from physiological conditions. In the 
fat blot, lipids are immobilized on a nitrocellulose membrane while in real cells lipids are part of 
membrane bilayers. The level of accessibility and manner of interaction between the protein and 
lipid may therefore be different in the fat blot from reality. Some methods to get around this 
problem include using lipid vesicles and protein in solution through floatation or sedimentation 
assays.  These methods however, could make results even less quantitative due to the multiple 
steps involved which could result in protein degradation (41). Other methods improve on the 
lack of quantitation by using lipid vesicles and fluorescently tagged protein that can be detected 
by flow cytometry in a shorter amount of time (41). Despite the improvements that these 
methods provide, they are more expensive and require more specialized equipment than fat blots. 
We used our homology model to predict lipid binding in ScSEC14. The prediction by the 
model that ScSEC14 would bind PI(5)P was proven true through binding experiments, validating 
the model. The model is attractive as it allows straight forward prediction of interactions that are 
difficult to measure experimentally. Because binding constants of protein lipid interactions are 
generally small, established methods such as isothermal calorimetry and surface plasmon 
resonance (40, 42) are almost always infeasible to use due to their need for high lipid and protein 
concentrations. Further, relatively easy methods such as fluorescence spectrometry that detect 
changes in the environment of the binding pocket due to ligand binding often prove to be 
ineffective, most likely due to the existence of fluorescent residues in parts of the protein other 
than the binding pocket (30). These residues that are not in the pocket contribute to the overall 
fluorescence and may mask small shifts due to binding in the emission spectra of the typtophans 
in the binding pocket. A work around this could be to mutate out all fluorescent residues except 
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those in the binding pocket but effects of the mutations on protein folding would have to be 
evaluated first. 
From the sequence alignment, we also see the characteristic variation in composition of 
the binding domain in SEC14 proteins. One striking difference between PATL1 and ScSEC14 is 
at Arg90 of PATL1. This is a positively charged residue in PATL1 whose position is occupied 
by a negatively charged Glu in ScSEC14. Such variation in these and other SEC14 proteins 
accounts for some of the great variety in binding profiles of different SEC14 proteins (3, 13, 20-
26). It is interesting that this position which interacts with the hydroxyl groups of the backbone 
can be either positively or negatively charged and still enable lipid binding. This could be one of 
the reasons why overall charge alone cannot be used to predict binding. 
The predictive model has implications in the design of proteins. With the knowledge of 
important residues, proteins can be modified to bind specific lipids. When these proteins are 
attached to fluorescent tags, they can be used as detection proteins for the localization of lipids in 
the cell. Some lipids such as PI(5)P do not presently have well characterized probes (17). 
Findings in our studies are instrumental in identifying some of the residues involved in binding 
to PI(5)P and in illuminating some of the interactions binding proteins have with the lipid. 
Furthermore, the structures of PATL1 and ScSEC14, which both bind to PI(5)P, can be a 







The next step in the project will be to verify mutations. Plasmid DNA will be extracted 
from each mutant and the DNA will be both enzymatically digested and Sanger sequenced. The 
mutant DNA will be transformed into BL21 cells to allow protein expression. All mutant 
proteins will then be characterized by SDS-PAGE, MALDI-TOF and CD. The proteins will also 
have their lipid binding profiles evaluated. 
Evaluating the lipid binding of the R11S mutant will allow us to further verify the role 
that Arg11 plays in PI(5)P binding while binding experiments on WT PATL1 and the R175S 
mutant would be used to shed light on Arg 175’s involvement in PI(3)P binding. The R90S and 
K179T mutant binding profiles will be useful for evaluating the necessity of these charged 
residues near the backbone and phosphate of the lipid’s head group for general lipid binding. The 
role that electrostatic interactions play in lipid binding would be assessed by testing whether 
binding of PI(4)P can be induced in the T172R mutant. All of these experiments will be useful 
for validating our binding model. 
Modeling can further be performed on different SEC14 proteins with binding profiles 
different from PATL1’s. The model investigated in this study can only predict binding to 
phosphoinositides because it is built off a structure of PATL1’s binding domain bound to PI. 
Creating a similar model in a different protein bound to a different lipid could offer the 
opportunity for different interactions to be predicted. This would increase the number of lipids 
for which binding can be predicted.  
Understanding binding to a wider variety of physiologically relevant lipids can lead to 
important predictions. When proteins are shown to bind to physiologically relevant lipids, 
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predictions of their function and mechanism of action can be made. For example, by 
understanding how the regulator of G-protein signaling protein RGS4 was associated with the 
plasma membrane, researchers gained insight into how it carried out its pheromone signal 
inhibition (43). 
Overall, modeling lipid binding will give insight into the mechanism of binding in lipid 
binding proteins which is tied to their function. This has far reaching implications in many 
aspects of human health as defects in lipid binding are tied to many cancers and neural 
degenerative diseases. A better understanding of these proteins will provide an avenue for 
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